The Past, Present, and Future of CIRT for Cervical Cancer: Implementation of “Immuno-CIRT” considering the radiation-induced anti-tumour immune response" - PDF Version
Wednesday, 16 November 2022 at 17.00 CET.
Dear Colleagues, Dear ENLIGHT members
After a short break we are back with our regular HITRIplus project seminars
For our next seminar we are very pleased to be hosting Dr. Noriyuki Okonogi from the National Institutes for Quantum Science and Technology / QST Hospital on Wednesday, 16 November 2022 at 17.00 CET.
Dr. Noriyuki Okonogi, Ph.D., M.D. is a radiation oncologist with expertise in intensity-modulated radiation therapy (IMRT), brachytherapy and particle therapy. He is chief physician (Radiation Oncologist) for the Department of Charged Particle Therapy Research at the National Institutes for Quantum Science and Technology / QST Hospital, where he leads the Clinical Research Group in pelvic tumour. In addition, he is a research fellow in Radiation Oncology at the Massachusetts General Hospital (Harvard Medical School) and a member of the Japanese Pharmaceuticals and Medical Devices Agency and of the forum for Nuclear Cooperation (Asia). HIs current scientific activity is focused on cervical cancer and pelvic tumour, Carbon-ion radiation therapy ((RT) basic and clinical researches), combination of RT and immunotherapy (clinical research) and radiation-induced cell response in non-irradiated cells. He is the recipient of multiple research funds from the prestigious Japan Society for the Promotion of Science.
Dr Okonoji will discuss "The Past, Present, and Future of CIRT for Cervical Cancer: Implementation of “Immuno-CIRT” considering the radiation-induced anti-tumor immune response"
Further information and registration can be found here: https://indico.cern.ch/event/1212090/
HITRIplus Communications Team